a public good project by the
Synthesis
Company
of California

© 2026

Esteban Braggio | doi.page

0 works0 citations0 h-index

Esteban Braggio

WinnMed(US)Mayo Clinic in Florida(US)

Publications by Year

Research Areas

Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders

Most-Cited Works

→ Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma(2007)983 cited
→ Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia(2019)722 cited
→ Clonal competition with alternating dominance in multiple myeloma(2012)632 cited
→ Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide(2011)597 cited
→ Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL(2017)411 cited
→ Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides(2012)404 cited

→ Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma(2020)

345 cited

→ Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes(2016)249 cited

→ Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas(2012)232 cited

→ Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial(2022)224 cited